Scholar Rock Holding (SRRK) Stock Rockets Up on Positive Phase …

Oct 9, 2024 · Scholar Rock Holding (SRRK) has shown a staggering 335% jump in share price following the success of its spinal muscular atrophy (SMA) treatment drug, Apitegromab, in a …

335%
OFF

Scholar Rock Holding (SRRK) Stock Rockets Up On Positive Phase …

2 weeks from now

Oct 9, 2024 · Scholar Rock Holding (SRRK) has shown a staggering 335% jump in share price following the success of its spinal muscular atrophy (SMA) treatment drug, Apitegromab, in a …

nasdaq.com

315%
OFF

Scholar Rock’s Stock Soars More Than 315% On Positive Trial Of ...

2 weeks from now

Oct 7, 2024 · Scholar Rock Holding Corp.’s stock soared more than 315% Monday to put it on track for its biggest ever one-day gain, after the clinical-stage biotech company said a late …

marketwatch.com

58%
OFF

Scholar Rock Sets Sights On $2 Billion Apitegromab Revenue

2 weeks from now

7 hours ago · SRRK Scholar Rock Holding Corp. $43.43 4.58% Watchlist. Overview. ... JP Morgan remains positive on Scholar Rock ... SRRK stock is up 4.89% at $43.56 at last check …

benzinga.com

364%
OFF

Here's Why Everybody's Talking About Scholar Rock Right Now

2 weeks from now

Oct 9, 2024 · Shares of Scholar Rock (NASDAQ: SRRK) shot 364% higher on Monday, Oct. 7, 2024. The market was reacting to surprisingly positive news regarding the clinical-stage …

nasdaq.com

8%
OFF

SRRK Stock Soars As Muscle Disease Drug Meets Phase III Study Goal

2 weeks from now

Oct 8, 2024 · Impact of SRRK News on Biohaven Stock. Interestingly, following the positive data readout from Scholar Rock’s late-stage SMA study, Biohaven BHVN also gained 10.8% on …

nasdaq.com

440%
OFF

Here’s Why Scholar Rock Holding Corporation (SRRK) Is …

2 weeks from now

2 days ago · Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 Returns as of December 31, 2024: 440% In Q4 2024, SRRK’s stock price returned nearly 440%, going from $8.01 on …

yahoo.com

$35.00
OFF

Buy Rating On Scholar Rock Holding: Promising Phase 3 Results …

2 weeks from now

Oct 7, 2024 · H.C. Wainwright analyst Andres Y. Maldonado reiterated a Buy rating on Scholar Rock Holding (SRRK – Research Report) today and set a price target of $35.00.. Andres Y. …

businessinsider.com

35%
OFF

Why Scholar Rock Holding Stock Soared Today - Nasdaq

2 weeks from now

Oct 12, 2023 · What happenedShares of Scholar Rock Holding Corp. (NASDAQ: SRRK) skyrocketed as much as 35% early Thursday, then settled to trade up 13.7% as of 3 p.m. ET …

nasdaq.com

8%
OFF

Scholar Rock (NASDAQ:SRRK) Trading 5.8% Higher - Here's Why

2 weeks from now

2 days ago · Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report)'s share price shot up 5.8% on Monday . The company traded as high as $43.50 and last traded at $42.85. 533,328 …

marketbeat.com

$64.48
OFF

Truist Financial Reaffirms Their Buy Rating On Scholar Rock …

2 weeks from now

3 days ago · Based on Scholar Rock Holding’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $64.48 million. In …

businessinsider.com

440%
OFF

Here’s Why Scholar Rock Holding Corporation (SRRK) Is …

2 weeks from now

Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 Returns as of December 31, 2024: 440% In Q4 2024, SRRK’s stock price returned nearly 440%, going from $8.01 on September 30 to …

msn.com

88%
OFF

Scholar Rock Holding . Stock Price Forecast. Should You Buy SRRK?

2 weeks from now

6 days ago · Sell candidate since Jan 10, 2025. The Scholar Rock Holding Corp. stock price fell by -0.88% on the last day (Friday, 10th Jan 2025) from $40.85 to $40.49.During the last …

stockinvest.us

FAQs about Scholar Rock Holding (SRRK) Stock Rockets Up on Positive Phase … Coupon?

Will Scholar Rock Holding Corp (SRRK) carry momentum?

SRRK is expected to carry momentum, which is evident from its research and development allocated to drug discovery and development. Aligning with its goal, Scholar Rock Holding Corp (NASDAQ:SRRK) completed several trials in the third quarter of 2024 and reported positive data from the Phase 3 trials of its leading drug, SAPPHIRE. ...

Should you buy scholar rock holding (SRRK) stock?

Scholar Rock Holding is rated a Strong Buy based on the cumulative recommendations of five analysts. The average price target for SRRK stock is $29.67, representing a potential 0.61% change from current levels. Scholar Rock has recently announced success in a phase 3 trial, sparking a remarkable surge in the company’s share price. ...

Why did scholar rock SRRK stock skyrocket 362% on Monday?

Written by Zacks Equity Research for Zacks -> Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted therapy, apitegromab, to treat spinal muscular atrophy (SMA). ...

Is Scholar Rock stock on track for a one-day gain?

Photo: pau barrena/Agence France-Presse/Getty Images Scholar Rock Holding Corp.’s stock soared more than 315% Monday to put it on track for its biggest ever one-day gain, after the clinical-stage biotech company said a late-stage trial of a treatment for spinal muscular atrophy met its main goal. ...

Who owns Scholar Rock Holding Corp (SRRK)?

The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA. View Scholar Rock Holding Corp. SRRK stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Where can I buy SRRK stock?

Shares of SRRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Scholar Rock own? ...